Following a difficult first quarter in which it reported anemic organic revenue growth of 3 percent, Waters last week reported that its organic second-quarter revenues rose 8 percent year over year. The rebound brought relief to investors and others in the life sciences capital equipment market who have been closely monitoring pharma spending trends. This week, Gene Cassis, Waters' vice president of investor relations, spoke with BioCommerce Week about reasons for the firm's improved quarterly results and the current capital equipment market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.